DP9 Stock Overview
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for DP9 from our risk checks.
Diploma PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£40.80 |
| 52 Week High | UK£43.40 |
| 52 Week Low | UK£29.60 |
| Beta | 0.73 |
| 1 Month Change | -0.49% |
| 3 Month Change | 8.51% |
| 1 Year Change | 37.84% |
| 3 Year Change | 20.00% |
| 5 Year Change | 120.78% |
| Change since IPO | 206.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| DP9 | DE Trade Distributors | DE Market | |
|---|---|---|---|
| 7D | 0.5% | -0.5% | 0.5% |
| 1Y | 37.8% | -4.9% | 1.3% |
Return vs Industry: DP9 exceeded the German Trade Distributors industry which returned -4.2% over the past year.
Return vs Market: DP9 exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| DP9 volatility | |
|---|---|
| DP9 Average Weekly Movement | 4.9% |
| Trade Distributors Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: DP9 has not had significant price volatility in the past 3 months.
Volatility Over Time: DP9's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,319 | Johnny Thomson | www.diplomaplc.com |
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Diploma PLC Fundamentals Summary
| DP9 fundamental statistics | |
|---|---|
| Market cap | €5.57b |
| Earnings (TTM) | €137.30m |
| Revenue (TTM) | €1.40b |
40.6x
P/E Ratio4.0x
P/S RatioIs DP9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DP9 income statement (TTM) | |
|---|---|
| Revenue | UK£1.20b |
| Cost of Revenue | UK£652.10m |
| Gross Profit | UK£548.20m |
| Other Expenses | UK£430.50m |
| Earnings | UK£117.70m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 45.67% |
| Net Profit Margin | 9.81% |
| Debt/Equity Ratio | 35.2% |
How did DP9 perform over the long term?
See historical performance and comparison